Global Med Technologies, Inc. Named One of the Fastest Growing Technology Companies in Deloitte's Colorado Technology Fast 50 Pr
October 10 2005 - 10:01AM
PR Newswire (US)
Global Med Ranks 35th With 57.2% Revenue Growth DENVER, Oct. 10
/PRNewswire-FirstCall/ -- Global Med Technologies, Inc. (OTC:GLOB)
(BULLETIN BOARD: GLOB) has been named in Deloitte's prestigious
Technology Fast 50 Program for Colorado, a ranking of the 50
fastest growing technology companies in the state by Deloitte &
Touche USA LLP, one of the nation's leading professional services
organizations. Rankings are based on the percentage revenue growth
over five years from 2000-2004. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Global
Med's CEO Dr. Mick Ruxin said, "We are delighted to have been
chosen by Deloitte's Colorado Technology Fast 50. This accolade
demonstrates the hard work and success Global Med has achieved over
the past 5 years and we look forward to building on this in the
future." Global Med's increase in revenues of 57.2% from 2000 to
2004 resulted in a 35th ranking in the Technology Fast 50 for
Colorado. Steve Yaroch, Technology, Media and Telecommunications
Group Leader for Deloitte & Touche LLP in Denver and Chair of
the 2005 Colorado Technology Fast 50, said, "Sustaining high
revenue growth over five years is an exceptional accomplishment. We
commend Global Med for making the commitment to technology and
delivering on the promise of market longevity. We are proud to
honor Global Med as a Deloitte Colorado Technology Fast 50 winner."
About Global Med Technologies, Inc. Global Med Technologies, Inc.
is an international e-Health, medical information technology
company, providing information management software products and
services to the healthcare industry. Its Wyndgate Technologies
division is a leading supplier of information management systems to
U.S. and international blood centers and hospital transfusion
centers. Current clients of Wyndgate's products and services manage
more than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Saharan Africa. Together, the
SafeTrace(R) donor management system and the SafeTrace Tx(R)*
advanced transfusion management system provide Vein-to-Vein(R)
tracking from donor collection to patient transfusion. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. About
Deloitte Deloitte & Touche USA LLP is the US member firm of
Deloitte Touche Tohmatsu. In the US, services are provided by the
subsidiaries of Deloitte & Touche USA LLP (Deloitte &
Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory
Services LLP, Deloitte Tax LLP and their subsidiaries), and not by
Deloitte & Touche USA LLP. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R),
Inc., +1-303-238-2000; or Investors, John Nesbett or Sally Martin,
both of The Investor Relations Group, +1-212-825-3210, for Global
Med Technologies, Inc. Web site: http://www.wyndgate.com/ Web site:
http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/
Copyright